Gradient Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Gradient Capital Advisors's AMGN Position: Q2 2026 in Review
Gradient Capital Advisors increased its Amgen (AMGN) stake by 0.03% in Q2 2026, buying an estimated $342 and bringing the position to 3,097 shares worth $1.12M. The position accounts for 0.26% of the portfolio, ranked #68.
Gradient Capital Advisors first reported a position in AMGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.15M in Q3 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Gradient Capital Advisors held 3,097 shares of Amgen worth $1.12M as of Q2 2026.
- Gradient Capital Advisors bought 1 Amgen share in Q2 2026, an estimated $342.
- Amgen made up 0.26% of Gradient Capital Advisors's portfolio in Q2 2026, its #68 holding.
- Gradient Capital Advisors first reported a position in Amgen in Q4 2019 and has held it in 26 quarters since.
- Gradient Capital Advisors's Amgen position peaked at $1.15M in Q3 2024.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Gradient Capital Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.